Aberrant Expression of FGFRL1 in Esophageal Cancer and Its Regulation by miR-107

BACKGROUND Fibroblast growth factor receptors are growth factor receptor tyrosine kinases, exerting their roles in embryogenesis, tissue homeostasis, and development of cancer. However, little is known about the expression and function of FGFRL1 in esophageal cancer (EC). METHODS We systematically evaluated the expression of FGFRL1 in TCGA and GETex datasets followed by expression analysis in EC cell lines and clinical specimens using immunofluorescence (IF) and immunohistochemistry (IHC) respectively. RESULTS GEPIA analysis on TCGA and GETex datasets identified significant upregulation of FGFRL1 in EC patients (n=182) compared to normal controls (n=286, p<0.05). IHC analysis showed significantly higher FGFRL1 expression in EC tissues as compared to the distant matched non-malignant tissues (p<0.001).  Immunoflourescence in EC cells suggested increased expression of FGFRL1 from WDSCC (KYSE30) to MDSCC (KYSE140) and finally to PDSCC (KYSE410). In-silico tools predicted miR-107 as most significant miRNA regulating FGFRL1 expression. qRT-PCR revealed miR-107 expression to be significantly and inversely correlated with FGFRL1 expression in 73% (22/30) EC tissues (p=0.015) and over-expression of miR-107 resulted in significantly decreased expression of FGFRL1 at mRNA (fold change=0.11, p=0.0016) as well as protein level in miR-107 versus NC treated cells. Luciferase reporter assay using FGFRL1-3'UTR further confirmed it to be a direct target of miR-107. CONCLUSION Our results herein document clinical as well as functional relevance of FGFRL1 in EC and its regulation by miR-107.

[1]  Zhen Sun,et al.  Lung CSC‐derived exosomal miR‐210‐3p contributes to a pro‐metastatic phenotype in lung cancer by targeting FGFRL1 , 2020, Journal of cellular and molecular medicine.

[2]  D M Parkin,et al.  Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods , 2018, International journal of cancer.

[3]  Xiaohui Xu,et al.  miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1 , 2018, Oncology letters.

[4]  Zhiyong Wu,et al.  FGFRL1 Promotes Ovarian Cancer Progression by Crosstalk with Hedgehog Signaling , 2018, Journal of immunology research.

[5]  G. Reid,et al.  A link between the fibroblast growth factor axis and the miR‐16 family reveals potential new treatment combinations in mesothelioma , 2017, Molecular oncology.

[6]  Yingyong Hou,et al.  High amplification of FGFR1 gene is a delayed poor prognostic factor in early stage ESCC patients , 2017, Oncotarget.

[7]  Rinu Sharma,et al.  miR-107 functions as a tumor suppressor in human esophageal squamous cell carcinoma and targets Cdc42. , 2017, Oncology reports.

[8]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[9]  Yuan Yang,et al.  MicroRNA-210 promotes cancer angiogenesis by targeting fibroblast growth factor receptor-like 1 in hepatocellular carcinoma. , 2016, Oncology reports.

[10]  Razelle Kurzrock,et al.  The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing , 2015, Clinical Cancer Research.

[11]  J. Zuo,et al.  MiR‐210 Links Hypoxia With Cell Proliferation Regulation in Human Laryngocarcinoma Cancer , 2015, Journal of cellular biochemistry.

[12]  Huan Liu,et al.  MicroRNA‐338‐3p Regulates Osteogenic Differentiation of Mouse Bone Marrow Stromal Stem Cells by Targeting Runx2 and Fgfr2 , 2014, Journal of cellular physiology.

[13]  Li Zhang,et al.  MiR-152 suppresses the proliferation and invasion of NSCLC cells by inhibiting FGF2 , 2014, Experimental & Molecular Medicine.

[14]  Heng Zhao,et al.  MicroRNA‐198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1 , 2014, Journal of cellular biochemistry.

[15]  Lingyi Chen,et al.  The oncoprotein HBXIP enhances angiogenesis and growth of breast cancer through modulating FGF8 and VEGF. , 2014, Carcinogenesis.

[16]  T. Betsuyaku,et al.  Molecular and Cellular Pathobiology Rapid Induction of Lung Adenocarcinoma by Fibroblast Growth Factor 9 Signaling through FGF Receptor 3 , 2013 .

[17]  Xiuchao Wang,et al.  Downregulation of microRNA-214 and overexpression of FGFR-1 contribute to hepatocellular carcinoma metastasis. , 2013, Biochemical and biophysical research communications.

[18]  M. Humbert,et al.  Pulmonary arterial hypertension , 2013, Orphanet Journal of Rare Diseases.

[19]  C. Taylor,et al.  An integrated genomic, transcriptional and protein investigation of FGFRL1 as a putative 4p16.3 deletion target in bladder cancer , 2013, Genes, chromosomes & cancer.

[20]  A. Saraya,et al.  Decreased levels of circulating and tissue miR-107 in human esophageal cancer , 2013, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.

[21]  Dawn M. Kilkenny,et al.  Fibroblast Growth Factor Receptor Like-1 (FGFRL1) Interacts with SHP-1 Phosphatase at Insulin Secretory Granules and Induces Beta-cell ERK1/2 Protein Activation* , 2013, The Journal of Biological Chemistry.

[22]  L. Zhuang,et al.  Interaction of the receptor FGFRL1 with the negative regulator Spred1. , 2011, Cellular signalling.

[23]  J. Wesche,et al.  Fibroblast growth factors and their receptors in cancer. , 2011, The Biochemical journal.

[24]  G. Tsujimoto,et al.  MicroRNA-210 Regulates Cancer Cell Proliferation through Targeting Fibroblast Growth Factor Receptor-like 1 (FGFRL1)* , 2010, The Journal of Biological Chemistry.

[25]  Florian Steinberg,et al.  Rapid Fusion and Syncytium Formation of Heterologous Cells upon Expression of the FGFRL1 Receptor* , 2010, The Journal of Biological Chemistry.

[26]  N. Turner,et al.  Fibroblast growth factor signalling: from development to cancer , 2010, Nature Reviews Cancer.

[27]  Florian Steinberg,et al.  The FGFRL1 Receptor Is Shed from Cell Membranes, Binds Fibroblast Growth Factors (FGFs), and Antagonizes FGF Signaling in Xenopus Embryos* , 2009, The Journal of Biological Chemistry.

[28]  Ricky T. Tong,et al.  Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. , 2009, Molecular cell.

[29]  D. Guidolin,et al.  miR-17 family of microRNAs controls FGF10-mediated embryonic lung epithelial branching morphogenesis through MAPK14 and STAT3 regulation of E-Cadherin distribution. , 2009, Developmental biology.

[30]  L. Zhuang,et al.  Characterization of the first FGFRL1 mutation identified in a craniosynostosis patient. , 2009, Biochimica et biophysica acta.

[31]  R. Lotan,et al.  Immunohistochemical Expression of Basic Fibroblast Growth Factor and Fibroblast Growth Factor Receptors 1 and 2 in the Pathogenesis of Lung Cancer , 2008, Clinical Cancer Research.

[32]  J. Luketich,et al.  Resection for esophageal cancer: strategies for optimal management. , 2008, The Annals of thoracic surgery.

[33]  Ajay N. Jain,et al.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.

[34]  Andrew D. Yates,et al.  A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer , 2005, Nature Genetics.

[35]  C. Dickson,et al.  Fibroblast growth factor signaling in tumorigenesis. , 2005, Cytokine & growth factor reviews.

[36]  V. P. Eswarakumar,et al.  Cellular signaling by fibroblast growth factor receptors. , 2005, Cytokine & growth factor reviews.

[37]  Robert J Linhardt,et al.  Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[38]  J. Bonifacino,et al.  Signals for sorting of transmembrane proteins to endosomes and lysosomes. , 2003, Annual review of biochemistry.

[39]  L. Zhuang,et al.  Characterization of FGFRL1, a Novel Fibroblast Growth Factor (FGF) Receptor Preferentially Expressed in Skeletal Tissues* , 2003, Journal of Biological Chemistry.

[40]  J. G. Park,et al.  Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. , 2001, Cancer research.

[41]  B. Trueb,et al.  Characterization of a novel protein (FGFRL1) from human cartilage related to FGF receptors. , 2000, Genomics.

[42]  Yang Yang,et al.  MiR-210-3p inhibits the tumor growth and metastasis of bladder cancer via targeting fibroblast growth factor receptor-like 1. , 2017, American journal of cancer research.

[43]  Y. Naito,et al.  Carbon monoxide enhance colonic epithelial restitution via FGF15 derived from colonic myofibroblasts. , 2010, Biochemical and biophysical research communications.

[44]  Peter D Siersema,et al.  Esophageal cancer. , 2008, Gastroenterology clinics of North America.